Duccio Papanti

1.1k total citations
26 papers, 724 citations indexed

About

Duccio Papanti is a scholar working on Clinical Psychology, Toxicology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Duccio Papanti has authored 26 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Psychology, 11 papers in Toxicology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Duccio Papanti's work include Psychedelics and Drug Studies (11 papers), Forensic Toxicology and Drug Analysis (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Duccio Papanti is often cited by papers focused on Psychedelics and Drug Studies (11 papers), Forensic Toxicology and Drug Analysis (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Duccio Papanti collaborates with scholars based in United Kingdom, Italy and Spain. Duccio Papanti's co-authors include Fabrizio Schifano, Laura Orsolini, John Corkery, Stefania Chiappini, Domenico De Berardis, Amira Guirguis, Arianna Giorgetti, Rita Santacroce, Giovanni Martinotti and Ornella Corazza and has published in prestigious journals such as BMJ, Journal of Psychopharmacology and Frontiers in Psychiatry.

In The Last Decade

Duccio Papanti

24 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duccio Papanti United Kingdom 16 353 306 266 204 96 26 724
Giulio Mannocchi Italy 19 453 1.3× 221 0.7× 267 1.0× 172 0.8× 92 1.0× 33 839
Gunilla Thelander Sweden 16 495 1.4× 281 0.9× 208 0.8× 175 0.9× 153 1.6× 20 864
Jeff Lapoint United States 9 550 1.6× 195 0.6× 631 2.4× 172 0.8× 165 1.7× 14 924
Roberta Tittarelli Italy 14 321 0.9× 206 0.7× 201 0.8× 149 0.7× 136 1.4× 39 747
Shawn P. Vorce United States 18 595 1.7× 323 1.1× 176 0.7× 259 1.3× 132 1.4× 25 898
Pierluigi Simonato Italy 11 186 0.5× 331 1.1× 91 0.3× 101 0.5× 173 1.8× 17 665
Sergio Abanades Spain 17 553 1.6× 421 1.4× 466 1.8× 444 2.2× 52 0.5× 26 1.4k
Eduardo Cinosi Italy 16 194 0.5× 497 1.6× 124 0.5× 134 0.7× 215 2.2× 36 1.1k
Thomas M. Penders United States 12 146 0.4× 186 0.6× 90 0.3× 76 0.4× 85 0.9× 24 569
Alessandro Vento Italy 16 215 0.6× 263 0.9× 92 0.3× 148 0.7× 31 0.3× 32 671

Countries citing papers authored by Duccio Papanti

Since Specialization
Citations

This map shows the geographic impact of Duccio Papanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duccio Papanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duccio Papanti more than expected).

Fields of papers citing papers by Duccio Papanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duccio Papanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duccio Papanti. The network helps show where Duccio Papanti may publish in the future.

Co-authorship network of co-authors of Duccio Papanti

This figure shows the co-authorship network connecting the top 25 collaborators of Duccio Papanti. A scholar is included among the top collaborators of Duccio Papanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duccio Papanti. Duccio Papanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corkery, John, Peter Streete, Hugh Claridge, et al.. (2019). Characteristics of deaths associated with kratom use. Journal of Psychopharmacology. 33(9). 1102–1123. 77 indexed citations
2.
Arya, Sidharth, et al.. (2019). Closing the gap between training needs and training provision in addiction medicine. BJPsych International. 17(2). 37–39. 9 indexed citations
3.
Orsolini, Laura, Stefania Chiappini, Duccio Papanti, et al.. (2019). The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective. Frontiers in Psychiatry. 10. 851–851. 27 indexed citations
4.
Orsolini, Laura, Stefania Chiappini, John Corkery, et al.. (2019). The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Review of Neurotherapeutics. 19(12). 1253–1264. 27 indexed citations
5.
Orsolini, Laura, Duccio Papanti, Domenico De Berardis, et al.. (2018). Psychedelic Fauna for Psychonaut Hunters: A Mini-Review. Frontiers in Psychiatry. 9. 153–153. 13 indexed citations
6.
Corkery, John, Amira Guirguis, Laura Orsolini, Duccio Papanti, & Fabrizio Schifano. (2017). An investigation into the relationship(s) between the different chemical classes of synthetic cathinones and their effects: desired, adverse and toxic. University of Hertfordshire Research Archive (University of Hertfordshire). 1 indexed citations
7.
Orsolini, Laura, Duccio Papanti, John Corkery, & Fabrizio Schifano. (2017). An insight into the deep web; why it matters for addiction psychiatry?. Human Psychopharmacology Clinical and Experimental. 32(3). 40 indexed citations
8.
Orsolini, Laura, Duccio Papanti, John Corkery, et al.. (2017). Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics’ (‘Spice’) Intake?. CNS & Neurological Disorders - Drug Targets. 16(5). 585–591. 12 indexed citations
9.
Martinotti, Giovanni, et al.. (2017). Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset. CNS & Neurological Disorders - Drug Targets. 16(5). 567–575. 50 indexed citations
10.
Luca, Maria Antonietta De, G. Di Chiara, Cristina Cadoni, et al.. (2017). Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update. CNS & Neurological Disorders - Drug Targets. 16(5). 598–609. 23 indexed citations
11.
Orsolini, Laura, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, & Domenico De Berardis. (2016). The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD). European Psychiatry. 33(S1). S310–S310. 3 indexed citations
12.
Schifano, Fabrizio, Laura Orsolini, Duccio Papanti, & John Corkery. (2016). NPS: Medical Consequences Associated with Their Intake. Current topics in behavioral neurosciences. 32. 351–380. 36 indexed citations
13.
Orsolini, Laura, et al.. (2016). Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?. Current Neuropharmacology. 15(5). 731–737. 18 indexed citations
14.
Orsolini, Laura, Duccio Papanti, R. Vecchiotti, et al.. (2016). Novel psychoactive substances. European Psychiatry. 33(S1). S59–S60. 6 indexed citations
15.
Orsolini, Laura, et al.. (2015). Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web‐based misusers′ experiences. Human Psychopharmacology Clinical and Experimental. 30(4). 255–261. 14 indexed citations
16.
Naviglio, Samuele, et al.. (2015). An adolescent with an altered state of mind. BMJ. 350(jan21 1). h299–h299. 8 indexed citations
17.
Orsolini, Laura, et al.. (2015). Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces. Human Psychopharmacology Clinical and Experimental. 30(4). 302–318. 48 indexed citations
18.
Papanti, Duccio, et al.. (2014). “Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics. Advances in Dual Diagnosis. 7(3). 137–148. 20 indexed citations
19.
20.
Papanti, Duccio, et al.. (2013). “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report. Human Psychopharmacology Clinical and Experimental. 28(4). 379–389. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulio Mannocchi Breakdown of academic impact, for papers by Gunilla Thelander Breakdown of academic impact, for papers by Jeff Lapoint Breakdown of academic impact, for papers by Roberta Tittarelli Breakdown of academic impact, for papers by Shawn P. Vorce Breakdown of academic impact, for papers by Pierluigi Simonato Breakdown of academic impact, for papers by Sergio Abanades Breakdown of academic impact, for papers by Eduardo Cinosi Breakdown of academic impact, for papers by Thomas M. Penders Breakdown of academic impact, for papers by Alessandro Vento
Rankless by CCL
2026